dostęp otwarty

Tom 2, Nr 4 (2017)
Wytyczne / stanowisko ekspertów
Pobierz cytowanie

Zaburzenia rozwoju płodu spowodowane spożywaniem alkoholu przez kobietę w ciąży. Karmienie piersią a alkohol

Zespół ekspertów
Ginekologia i Perinatologia Praktyczna 2017;2(4):176-190.

dostęp otwarty

Tom 2, Nr 4 (2017)
Rekomendacje

Streszczenie

Brak

Streszczenie

Brak
Pobierz cytowanie
Informacje o artykule
Tytuł

Zaburzenia rozwoju płodu spowodowane spożywaniem alkoholu przez kobietę w ciąży. Karmienie piersią a alkohol

Czasopismo

Ginekologia i Perinatologia Praktyczna

Numer

Tom 2, Nr 4 (2017)

Typ artykułu

Wytyczne / stanowisko ekspertów

Strony

176-190

Rekord bibliograficzny

Ginekologia i Perinatologia Praktyczna 2017;2(4):176-190.

Autorzy

Zespół ekspertów

Referencje (96)
  1. Burd L, Blair J, Dropps K. Prenatal alcohol exposure, blood alcohol concentrations and alcohol elimination rates for the mother, fetus and newborn. J Perinatol. 2012; 32(9): 652–659.
  2. Lemoine P, Harousseau H, Borteyru JP, et al. Les enfants de parents alcoolique. Ouest Med. 1968; 21: 476–82.
  3. May PA, Gossage JP, White-Country M, et al. Alcohol consumption and other maternal risk factors for fetal alcohol syndrome among three distinct samples of women before, during, and after pregnancy: the risk is relative. Am J Med Genet C Semin Med Genet. 2004; 127C(1): 10–20.
  4. O'Leary CM, Nassar N, Kurinczuk JJ, et al. Prenatal alcohol exposure and risk of birth defects. Pediatrics. 2010; 126(4): e843–e850.
  5. Jakubczyk A. Uzależnienie, picie szkodliwe i ryzykowne – podstawowe definicje w świetle najważniejszych systemów klasyfikacyjnych. [W:] M. Wojnar (red.) Medyczne aspekty uzależnienia od alkoholu, PARPA Warszawa, 2017.
  6. Abel EL, Sokol RJ. Fetal alcohol syndrome is now leading cause of mental retardation. Lancet. 1986; 2(8517): 1222.
  7. Jones KL, Smith DW, Ulleland CN, et al. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet. 1973; 1(7815): 1267–1271.
  8. Stratton K, Howe C, Battaglia F. Fetal Alcohol Syndrome: Diagnosis, Epidemilogy, Prevention, and Treatment. Institute of Medicine, Washington 1996.
  9. Hagda JF, Balachova T, Bertrand J, et al. Neurobehavioral disorder associated with prenatal alcohol exposure. Pediatrics. 2014; 27: 95–7.
  10. Popova S, Lange S, Probst C, et al. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet. 2017; 5(3): e290–e299.
  11. Carpenter B. Pedagogically bereft! Improving learning outcomes for children with foetal alcohol spectrum disorders. BJSE. 2011; 38(1): 37–43.
  12. Petković G, Barišić I. Prevalence of fetal alcohol syndrome and maternal characteristics in a sample of schoolchildren from a rural province of Croatia. Int J Environ Res Public Health. 2013; 10(4): 1547–1561.
  13. May PA, Gossage JP. Maternal risk factors for fetal alcohol spectrum disorders: not as simple as it might seem. Alcohol Res Health. 2011; 34(1): 15–26.
  14. Okulicz-Kozaryn K, Borkowska M, Brzózka K. FASD Prevalence among Schoolchildren in Poland. J Appl Res Intellect Disabil. 2017; 30(1): 61–70.
  15. Chudley AE, Conry J, Cook JL, et al. Public Health Agency of Canada's National Advisory Committee on Fetal Alcohol Spectrum Disorder. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ. 2005; 172(5 Suppl): S1–S21.
  16. May PA, Gossage JP. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res Health. 2001; 25(3): 159–167.
  17. Astley SJ. Profile of the first 1,400 patients receiving diagnostic evaluations for fetal alcohol spectrum disorder at the Washington State Fetal Alcohol Syndrome Diagnostic & Prevention Network. Can J Clin Pharmacol. 2010; 17(1): e132–e164.
  18. May PA, Keaster C, Bozeman R, et al. Prevalence and characteristics of fetal alcohol syndrome and partial fetal alcohol syndrome in a Rocky Mountain Region City. Drug Alcohol Depend. 2015; 155: 118–127.
  19. Roozen S, Peters GJY, Kok G, et al. Worldwide Prevalence of Fetal Alcohol Spectrum Disorders: A Systematic Literature Review Including Meta-Analysis. Alcohol Clin Exp Res. 2016; 40(1): 18–32.
  20. Centers for Disease Control and Prevention (CDC). Alcohol use among pregnant and nonpregnant women of childbearing age - United States, 1991-2005. MMWR Morb Mortal Wkly Rep. 2009; 58(19): 529–532.
  21. Astley SJ, Stachowiak J, Clarren SK, et al. Application of the fetal alcohol syndrome facial photographic screening tool in a foster care population. J Pediatr. 2002; 141(5): 712–717.
  22. Hoyme HE, May PA, Kalberg WO, et al. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 institute of medicine criteria. Pediatrics. 2005; 115(1): 39–47.
  23. Hoyme HE, Kalberg WO, Elliott AJ, et al. Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders. Pediatrics. 2016; 138(2).
  24. Chudley AE, Conry J, Cook JL, et al. Public Health Agency of Canada's National Advisory Committee on Fetal Alcohol Spectrum Disorder. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ. 2005; 172(5 Suppl): S1–S21.
  25. Cook JL, Green CR, Lilley CM, et al. Canada Fetal Alcohol Spectrum Disorder Research Network. Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan. CMAJ. 2016; 188(3): 191–197.
  26. Astley SJ, Clarren SK. Diagnosing the full spectrum of fetal alcohol-exposed individuals: introducing the 4-digit diagnostic code. Alcohol Alcohol. 2000; 35(4): 400–410.
  27. Riley EP, Infante MA, Warren KR. Fetal alcohol spectrum disorders: an overview. Neuropsychol Rev. 2011; 21(2): 73–80.
  28. Lebel C, Roussotte F, Sowell ER. Imaging the impact of prenatal alcohol exposure on the structure of the developing human brain. Neuropsychol Rev. 2011; 21(2): 102–118.
  29. Wozniak JR, Muetzel RL. What does diffusion tensor imaging reveal about the brain and cognition in fetal alcohol spectrum disorders? Neuropsychol Rev. 2011; 21(2): 133–147.
  30. Astley S, Aylward E, Olson H, et al. Magnetic Resonance Imaging Outcomes From a Comprehensive Magnetic Resonance Study of Children With Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res. 2009; 33(10): 1671–1689.
  31. Heller M, Burd L. Review of ethanol dispersion, distribution, and elimination from the fetal compartment. Birth Defects Res A Clin Mol Teratol. 2014; 100(4): 277–283.
  32. Jones KL, Jones MC, del Campo M. Smith”s Recognizable patterns of human malformation. Elsevier Saunders 2013.
  33. Feldman HS, Jones KL, Lindsay S, et al. Prenatal alcohol exposure patterns and alcohol-related birth defects and growth deficiencies: a prospective study. Alcohol Clin Exp Res. 2012; 36(4): 670–676.
  34. Abel EL, Hannigan JH. Maternal risk factors in fetal alcohol syndrome: provocative and permissive influences. Neurotoxicol Teratol. 1995; 17(4): 445–462.
  35. Warren KR, Li TK. Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders. Birth Defects Res A Clin Mol Teratol. 2005; 73(4): 195–203.
  36. Wass TS, Persutte WH, Hobbins JC. The impact of prenatal alcohol exposure on frontal cortex development in utero. Am J Obstet Gynecol. 2001; 185(3): 737–742.
  37. Handmaker NS, Rayburn WF, Meng C, et al. Impact of alcohol exposure after pregnancy recognition on ultrasonographic fetal growth measures. Alcohol Clin Exp Res. 2006; 30(5): 892–898.
  38. Kfir M, Yevtushok L, Onishchenko S, et al. Can prenatal ultrasound detect the effects of in-utero alcohol exposure? A pilot study. Ultrasound Obstet Gynecol. 2009; 33(6): 683–689.
  39. Montag AC, Hull AD, Yevtushok L, et al. CIFASD. Second-Trimester Ultrasound as a Tool for Early Detection of Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res. 2016; 40(11): 2418–2425.
  40. Handmaker NS, Wilburn P. Motivational Interventions in Prenatal Clinics Alcohol Research & Health Vol. Alcohol Res Health. 2001(3): 219–229.
  41. Floyd RL, Weber MK, Denny C, et al. Prevention of fetal alcohol spectrum disorders. Dev Disabil Res Rev. 2009; 15(3): 193–199.
  42. Wright TE, Terplan M, Ondersma SJ, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol. 2016; 215(5): 539–547.
  43. Anderson P, Gual A, Colom J. Alkohol i podstawowa opieka zdrowotna. Kliniczne wytyczne rozpoznawania i krótkiej interwencji (Alcohol and Primary Health Care: Clinical Guidelines on Identification and Brief Interventions. Department of Health of the Government of Catalonia, Barcelona. PARPAMEDIA, Warszawa 2005.
  44. McNamara TK, Orav EJ, Wilkins-Haug L, et al. Risk during pregnancy--self-report versus medical record. Am J Obstet Gynecol. 2005; 193(6): 1981–1985.
  45. Hughes SC, Chambers CD, Kassem N, et al. Inconsistent report of pre-pregnancy-recognition alcohol use by Latinas. Matern Child Health J. 2009; 13(6): 857–864.
  46. Sobell LC, Agrawal S, Sobell MB, et al. Comparison of a quick drinking screen with the timeline followback for individuals with alcohol problems. J Stud Alcohol. 2003; 64(6): 858–861.
  47. Dum M, Sobell LC, Sobell MB, et al. A Quick Drinking Screen for identifying women at risk for an alcohol-exposed pregnancy. Addict Behav. 2009; 34(9): 714–716.
  48. Balachova T, Sobell LC, Agrawal S, et al. Evaluating alcohol use among Russian women at risk for an alcohol-exposed pregnancy: A comparison of three measures of alcohol use. J Ethn Subst Abuse. 2016 [Epub ahead of print]: 1–11.
  49. Sobell L, Sobell M. Timeline follow-back: A technique for assessing selfreported alcohol consumption. Measuring Alcohol Consumption. 1992: 41–72.
  50. Lange S, Shield K, Koren G, et al. A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis. BMC Pregnancy Childbirth. 2014; 14: 127.
  51. McQuire C, Paranjothy S, Hurt L, et al. Objective Measures of Prenatal Alcohol Exposure: A Systematic Review. Pediatrics. 2016; 138(3).
  52. Nelson L. Goldfrank’s Toxicologic Emergencies. McGraw-Hill Medical, New York 2011.
  53. Carson G. Alcohol use and pregnancy consensus clinical guidelines. Society of Obstetricians and Gynaecologists of Canada. www.guideline.gov.
  54. Australian guidelines to reduce health risks from drinking alcohol. National Health and Medical Research Council. www.nhmrc.gov.au.
  55. Matheson I, Kristensen K, Lunde PK. Drug utilization in breast-feeding women. A survey in Oslo. Eur J Clin Pharmacol. 1990; 38(5): 453–459.
  56. Little RE, Lambert MD, Worthington-Roberts B. Drinking and smoking at 3 months postpartum by lactation history. Paediatr Perinat Epidemiol. 1990; 4(3): 290–302.
  57. Parackal S, Ferguson E, Harraway J. Alcohol and tobacco consumption among 6-24-months post-partum New Zealand women. Matern Child Nutr. 2007; 3(1): 40–51.
  58. Breslow RA, Falk DE, Fein SB, et al. Alcohol consumption among breastfeeding women. Breastfeed Med. 2007; 2(3): 152–157.
  59. Giglia RC, Binns CW. Patterns of alcohol intake of pregnant and lactating women in Perth, Australia. Drug Alcohol Rev. 2007; 26(5): 493–500.
  60. Maloney E, Hutchinson D, Burns L, et al. Prevalence and predictors of alcohol use in pregnancy and breastfeeding among Australian women. Birth. 2011; 38(1): 3–9.
  61. Alvik A, Haldorsen T, Lindemann R. Alcohol consumption, smoking and breastfeeding in the first six months after delivery. Acta Paediatr. 2006; 95(6): 686–693.
  62. Giglia RC, Binns CW. Alcohol, pregnancy and breastfeeding; a comparison of the 1995 and 2001 National Health Survey data. Breastfeed Rev. 2008; 16(1): 17–24.
  63. Pepino MY, Mennella JA. Advice given to women in Argentina about breast-feeding and the use of alcohol. Rev Panam Salud Publica. 2004; 16(6): 408–414.
  64. Haastrup MB, Pottegård A, Damkier P. Alcohol and breastfeeding. Basic Clin Pharmacol Toxicol. 2014; 114(2): 168–173.
  65. Lawton ME. Alcohol in breast milk. Aust N Z J Obstet Gynaecol. 1985; 25(1): 71–73.
  66. Dietary Guidelines for Americans. 2010. United States Department of Agriculture. Center for Nutrition Policy and Promotion. www.cnpp.usda.gov/dietaryguidelines (2010).
  67. Healthy habits before, during and after pregnancy. 1st edn: The Danish Health and Medicines Authority, 2010. www.sst.dk/udgivelser/2010 (2010).
  68. American Academy of Pediatrics. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2012; 129: 827–841.
  69. American Academy of Pediatrics. Committee on Drugs: The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update on Selected Topics. Pediatrics. 2013; 132: e796–e809.
  70. RARHA (2016) Comparative monitoring of alcohol epidemiology across the EU. Baseline assessment and suggestions for future action. Synthesis report. RARHA Work Package 4. http://www.parpa.pl/images/file/Comparative%20monitoring%20of%20alcohol%20epidemiology%20across%20the%20EU.pdf (2016).
  71. Tough S, Tofflemire K, Clarke M, et al. Do women change their drinking behaviors while trying to conceive? An opportunity for preconception counseling. Clin Med Res. 2006; 4(2): 97–105.
  72. Wojtyła, A., Kapka-Skrzypczak, L., Diatczyk, J., Fronczak, A., Paprzycki, P. Alcohol-related Developmental Origin of Adult Health – population studies in Poland among mothers and newborns (2010-2012). Ann Agric Environ Med. 2012; 19(3): 365–377.
  73. Wdowiak A, Pucek W, Makara-Studzińska M, et al. Ocena wybranych zachowań zdrowotnych kobiet leczonych technologiami rozrodu wspomaganego z powodu niepłodności. European J Med Technologies. 2014; 3(4): 7–16.
  74. Green PP, McKnight-Eily LR, Tan CH, et al. Vital Signs: Alcohol-Exposed Pregnancies--United States, 2011-2013. MMWR Morb Mortal Wkly Rep. 2016; 65(4): 91–97.
  75. Anderson P, Gual A, Colom J. Alkohol i podstawowa opieka zdrowotna. Kliniczne wytyczne rozpoznawania i krótkiej interwencji (Alcohol and Primary Health Care: Clinical Guidelines on Identification and Brief Interventions. Department of Health of the Government of Catalonia, Barcelona. PARPAMEDIA, Warszawa 2005.
  76. Sokol R, Martier S, Ager J. The T-ACE questions: Practical prenatal detection of risk-drinking. Am J Obstet Gynecol. 1989; 160(4): 863–870.
  77. Russell M, Martier SS, Sokol RJ, et al. Screening for pregnancy risk-drinking. Alcohol Clin Exp Res. 1994; 18(5): 1156–1161.
  78. Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993; 88(6): 791–804.
  79. Bradley KA, DeBenedetti AF, Volk RJ, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007; 31(7): 1208–1217.
  80. Dum M, Sobell LC, Sobell MB, et al. A Quick Drinking Screen for identifying women at risk for an alcohol-exposed pregnancy. Addict Behav. 2009; 34(9): 714–716.
  81. Wright TE, Terplan M, Ondersma SJ, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol. 2016; 215(5): 539–547.
  82. Joya X, Marchei E, Salat-Batlle J, et al. Fetal exposure to ethanol: relationship between ethyl glucuronide in maternal hair during pregnancy and ethyl glucuronide in neonatal meconium. Clin Chem Lab Med. 2016; 54(3): 427–435.
  83. Miller WR, Rollnick S. Dialog motywujący – Jak pomóc ludziom w zmianie. Wydawnictwo Uniwersytetu Jagiellońskiego, Kraków 2014.
  84. Britt E, Hudson SM, Blampied NM. Motivational interviewing in health settings: a review. Patient Educ Couns. 2004; 53(2): 147–155.
  85. Stade BC, Bailey C, Dzendoletas D, et al. Psychological and/or educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy. Cochrane Database Syst Rev. 2009(2): CD004228.
  86. Morton K, Beauchamp M, Prothero A, et al. The effectiveness of motivational interviewing for health behaviour change in primary care settings: a systematic review. Health Psychol Rev. 2015; 9(2): 205–223.
  87. Lundahl B, Burke BL. The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. J Clin Psychol. 2009; 65(11): 1232–1245.
  88. Handmaker NS, Miller WR, Manicke M. Findings of a pilot study of motivational interviewing with pregnant drinkers. J Stud Alcohol. 1999; 60(2): 285–287.
  89. Floyd RL, Sobell M, Velasquez MM, et al. Project CHOICES Efficacy Study Group. Preventing alcohol-exposed pregnancies: a randomized controlled trial. Am J Prev Med. 2007; 32(1): 1–10.
  90. Ingersoll KS, Ceperich SD, Hettema JE, et al. Preconceptional motivational interviewing interventions to reduce alcohol-exposed pregnancy risk. J Subst Abuse Treat. 2013; 44(4): 407–416.
  91. Ceperich SD, Ingersoll KS. Motivational interviewing + feedback intervention to reduce alcohol-exposed pregnancy risk among college binge drinkers: determinants and patterns of response. J Behav Med. 2011; 34(5): 381–395.
  92. Elsinga J, de Jong-Potjer LC, van der Pal-de Bruin KM, et al. The effect of preconception counselling on lifestyle and other behaviour before and during pregnancy. Womens Health Issues. 2008; 18(6 Suppl): S117–S125.
  93. Ondersma SJ, Svikis DS, Thacker LR, et al. A randomised trial of a computer-delivered screening and brief intervention for postpartum alcohol use. Drug Alcohol Rev. 2016; 35(6): 710–718.
  94. Lui S, Terplan M, Smith EJ. Psychosocial interventions for women enrolled in alcohol treatment during pregnancy. Cochrane Database Syst Rev. 2008(3): CD006753.
  95. Hussein N, Kai J, Qureshi N. The effects of preconception interventions on improving reproductive health and pregnancy outcomes in primary care: A systematic review. Eur J Gen Pract. 2016; 22(1): 42–52.
  96. Scobie G, Woodman K. Interventions to reduce alcohol consumption during pregnancy. NHS Health Scotland, Edinburgh 2017.

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl